Test Price
2,800 AED✅ Home Collection Available
CLIC2 Gene X-Linked Intellectual Disability Type 32 Genetic Test (NGS) in UAE | 2,800 AED | 2026 DHA Guidelines
تحليل جين CLIC2 لاضطراب الإعاقة الذهنية المرتبط بالكروموسوم X النوع 32 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Accuracy Guarantee
99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics
Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM).
Clinical Guidance
Telephonic Post-Test Clinical Guidance for result interpretation with a DHA-licensed medical geneticist.
Insurance
Direct Billing Verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي: يوفر تحليل تسلسل جين CLIC2 باستخدام تقنية التسلسل الجزيئي من الجيل التالي (NGS) تشخيصاً دقيقاً للإعاقة الذهنية المرتبطة بالكروموسوم X من النوع 32، وهو اختبار جيني معتمد من هيئة الصحة بدبي وفقاً لأعلى معايير الجودة العالمية. نضمن سرية البيانات وحماية الخصوصية وفقاً لقانون حماية البيانات الشخصية الإماراتي، مع خدمة سحب عينات منزلية معقمة ومتابعة طبية متخصصة.
Test Overview
The CLIC2 NGS test sequences the entire coding region of the chloride intracellular channel 2 gene to identify pathogenic variants responsible for X-linked intellectual disability type 32. This condition primarily affects males, presenting with developmental delay, cognitive impairment, and often behavioural abnormalities; early molecular confirmation enables tailored medical management and genetic counselling.
يقوم الاختبار بفحص جين CLIC2 للكشف عن الطفرات المسببة للإعاقة الذهنية المرتبطة بالكروموسوم X النوع 32، مما يسمح بتشخيص مبكر وإرشاد وراثي دقيق للعائلات المعرضة.
| Features | Our Test – CLIC2 NGS | Closest Alternative – Chromosomal Microarray (CMA) |
|---|---|---|
| Precision | Single‑nucleotide variant & small indel detection within CLIC2 | Detects only large deletions/duplications >50 kb; misses point mutations |
| Method | Next‑Generation Sequencing (Illumina) with Sanger confirmation | Array‑based comparative genomic hybridisation (aCGH) |
| Turnaround Time | 3–4 weeks | 2–4 weeks |
| Clinical Sensitivity for CLIC2 | >99% for pathogenic variants in the target gene | Near 0% for intragenic mutations; not designed for single‑gene disorders |
Physician Insight & Safety Protocol
“As a practicing neurologist, I recognize that a CLIC2 pathogenic result carries profound implications for developmental prognosis and family planning. This genetic test must always be interpreted within the full clinical picture—an abnormal result confirms the molecular diagnosis, but normal findings do not exclude other genetic or acquired causes of intellectual disability. Please ensure that post‑test genetic counselling is completed before making any major medical decisions.”
— Dr. PRABHAKAR REDDY, Neurologist & DHA-Licensed Consultant (DHA: 61713011)
⚠ Medication Warning
Do not discontinue prescribed medication or modify any therapy without consulting your treating physician. This genetic test is for diagnostic and counselling purposes only; it does not replace ongoing clinical management.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Active infection or fever (>38°C) at time of blood draw; history of heparin‑induced thrombocytopenia (for FTA card method).
- Exclusion: Patient unable to provide voluntary informed consent (or legal guardian consent for minors, as per UAE CDS Law 2026).
- Emergency Red Flags: If the patient experiences acute neurological decompensation (new‑onset seizures, loss of consciousness, or stroke‑like symptoms), seek immediate medical attention — do not wait for genetic results.
- Emergency Red Flags: Any unexplained bleeding or severe hematoma after sample collection requires urgent medical review.
Patient FAQ & Clinical Guidance
1. What is the CLIC2 gene test, and why is it performed?
The CLIC2 NGS test analyzes the entire coding region of the CLIC2 gene to detect pathogenic variants causing X‑linked intellectual disability type 32, aiding accurate diagnosis.
يقوم تحليل جين CLIC2 بفحص الترميز الكامل للجين للكشف عن الطفرات المسببة للإعاقة الذهنية المرتبطة بالكروموسوم X، مما يساعد في التشخيص الدقيق.
2. How long do results take, and what sample is required?
A standard blood sample (or one drop of blood on an FTA card) is needed; results are reported within 3 to 4 weeks via DHA‑accredited laboratory protocols.
يتم سحب عينة دم بسيطة (أو قطرة دم على بطاقة FTA) وتظهر النتائج خلال 3 إلى 4 أسابيع عبر مختبر معتمد من هيئة الصحة بدبي.
3. What should I expect during the home collection visit?
A DHA‑licensed phlebotomist arrives with a temperature‑controlled transport kit, performs a quick venipuncture, and completes the cold‑chain logistics within 45 minutes.
يحضر أخصائي سحب دم مرخص من هيئة الصحة بدبي مع حقيبة تبريد معقمة، ويقوم بسحب العينة خلال زيارة منزلية لا تستغرق أكثر من 45 دقيقة.
UAE Legal & Compliance: This genetic is performed in strict accordance with Federal Decree‑Law No. 41 of 2024 (Art. 87), the UAE CDS Law 2026 (including mandatory guardian consent for minors), and UAE Personal Data Protection Law (PDPL). Our facilities hold ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) and are licensed by Dubai Health Authority (Facility License 9834453). All patient data is encrypted and processed exclusively within the UAE.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians